Shawn Cross
CIK 1734779 · Chief Financial Officer · last filed 2026-04-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.57M
Companies
3
Total Filings
34
Lifetime Open-Market Net
-$1.90M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCRX | Chief Financial Officer | 105,341 | $24.38 | $2.57M | -$1.52M | 7 | 2026-04-24 |
| Cyclo Therapeutics, Inc. (CYTHW) Delisted | Director | 136,346 | $0.03 | $4.4K | $0 | 5 | 2025-03-03 |
| Applied Molecular Transport Inc. (AMTI) Delisted | CEO & Chair of the Board | 0 | $0.26 | $0 | -$383.5K | 15 | 2023-12-28 |
Recent Filings · Page 2 of 4
34 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-13 | PCRX | Sell (S) | −12,060 | -$266.4K | EDGAR |
| 2025-11-10 | PCRX | Notice (144) | −12,060 | -$266.4K | EDGAR |
| 2025-11-03 | PCRX | Tax (F) | −6,690 | -$143.0K | EDGAR |
| 2025-03-03 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +28,597 | $0 | EDGAR |
| 2024-11-18 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +17,228 | $0 | EDGAR |
| 2024-11-05 | PCRX | Grant (A) | +75,000 | $0 | EDGAR |
| 2024-08-20 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +9,028 | $0 | EDGAR |
| 2024-06-05 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +8,887 | $0 | EDGAR |
| 2023-12-28 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +72,606 | $0 | EDGAR |
| 2023-12-28 | Applied Molecular Transport Inc. (AMTI) Delisted | Disp (D) | −545,499 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.